Jennifer Buell - Net Worth and Insider Trading
Jennifer Buell Net Worth
The estimated net worth of Jennifer Buell is at least $4,903 dollars as of 2024-12-28. Jennifer Buell is the Chief Communications Officer of Agenus Inc and owns about 1,783 shares of Agenus Inc (AGEN) stock worth over $4,903. Details can be seen in Jennifer Buell's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Jennifer Buell has not made any transactions after 2017-12-12 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Jennifer Buell
Jennifer Buell Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Jennifer Buell owns 3 companies in total, including Protagenic Therapeutics Inc (PTIX) , Agenus Inc (AGEN) , and MiNK Therapeutics Inc (INKT) .
Click here to see the complete history of Jennifer Buell’s form 4 insider trades.
Insider Ownership Summary of Jennifer Buell
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| PTIX | Protagenic Therapeutics Inc | 2020-07-18 | director |
| AGEN | Agenus Inc | 2018-11-07 | Chief Operating Officer |
| INKT | MiNK Therapeutics Inc | 2021-10-13 | director & See Remarks |
Jennifer Buell Latest Holdings Summary
Jennifer Buell currently owns a total of 1 stock. Jennifer Buell owns 1,783 shares of Agenus Inc (AGEN) as of December 12, 2017, with a value of $4,903.
Latest Holdings of Jennifer Buell
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| AGEN | Agenus Inc | 2017-12-12 | 1,783 | 2.75 | 4,903 |
Holding Weightings of Jennifer Buell
Jennifer Buell Form 4 Trading Tracker
According to the SEC Form 4 filings, Jennifer Buell has made a total of 0 transactions in Agenus Inc (AGEN) over the past 5 years. The most-recent trade in Agenus Inc is the sale of 176 shares on December 12, 2017, which brought Jennifer Buell around $12,148.
Insider Trading History of Jennifer Buell
- 1
Jennifer Buell Trading Performance
Jennifer Buell Ownership Network
Jennifer Buell Owned Company Details
What does Protagenic Therapeutics Inc do?
Who are the key executives at Protagenic Therapeutics Inc?
Jennifer Buell is the director of Protagenic Therapeutics Inc. Other key executives at Protagenic Therapeutics Inc include Chief Financial Officer Alexander K. Arrow , director & 10 percent owner & See Remarks Garo H Armen , and COO / Interim President Robert Ziroyan .
Protagenic Therapeutics Inc (PTIX) Insider Trades Summary
Over the past 18 months, Jennifer Buell made no insider transaction in Protagenic Therapeutics Inc (PTIX). Other recent insider transactions involving Protagenic Therapeutics Inc (PTIX) include a net purchase of 8,000 shares made by Alexander K. Arrow ,
In summary, during the past 3 months, insiders sold 0 shares of Protagenic Therapeutics Inc (PTIX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Protagenic Therapeutics Inc (PTIX) were sold and 8,000 shares were bought by its insiders, resulting in a net purchase of 8,000 shares.
Protagenic Therapeutics Inc (PTIX)'s detailed insider trading history can be found in Insider Trading Tracker table.
Protagenic Therapeutics Inc Insider Transactions
Jennifer Buell Mailing Address
Above is the net worth, insider trading, and ownership report for Jennifer Buell. You might contact Jennifer Buell via mailing address: 3 Forbes Road, Lexington Ma 02421.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
